Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novet Bio-Tech is a biotechnology company headquartered in Beijing, China, specializing in the research, development, and production of in vitro diagnostic (IVD) products. The company's core business is divided into three primary sectors: animal health diagnostics, food safety testing, and human clinical diagnostics. Novet Bio-Tech offers a comprehensive portfolio of rapid test kits and ELISA assays designed for the detection of infectious diseases in livestock and pets, as well as antibiotic residues and contaminants in food products. With a strong focus on immunological and molecular diagnostic technologies, the company provides reliable testing solutions to veterinary clinics, agricultural enterprises, and food safety regulators globally. Their products are used to monitor and control major animal diseases such as Foot-and-Mouth Disease and Swine Fever. The company maintains high quality standards, holding ISO 9001 and ISO 13485 certifications for its manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novet Bio-Tech.